Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Bacharach

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of Cataract and Refractive Surgery|August 5, 2014
Efficacy of trabecular bypass stent through 2 years: data from the United States pivotal trialJason Bacharach
Clinical Ophthalmology (Auckland, N.Z.)|April 11, 2025
The Effect of Eyedrop Size on Pupillary Dilation Using the Nanodropper Bottle AdapterAudrey Chow, Jin Choi, Jason Bacharach
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 14, 2003
Comparison of the efficacy of the fixed-combination timolol/dorzolamide versus concomitant administration of timolol and dorzolamideJason Bacharach, Maria F Delgado, Andrew G Iwach
Therapeutic Advances in Ophthalmology|October 18, 2024
Early diagnostics and interventional glaucomaTiciana De Francesco, Jason Bacharach, Oluwatosin Smith, et al.
Journal of Cataract and Refractive Surgery|August 21, 2020
Impact of dexamethasone intraocular suspension 9% on intraocular pressure after routine cataract surgery: post hoc analysisCynthia Matossian, John Hovanesian, Jason Bacharach, et al.
Eye (London, England)|April 30, 2021
A review of acquired blepharoptosis: prevalence, diagnosis, and current treatment optionsJason Bacharach, Wendy W Lee, Andrew R Harrison, et al.
Clinical Ophthalmology (Auckland, N.Z.)|January 27, 2025
Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE StudyJason Bacharach, Ehsan Sadri, Gagan Sawhney, et al.
Ophthalmology. Glaucoma|March 5, 2025
Sepetaprost 0.002% Noninferiority vs. Timolol 0.5% in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: ANGEL-2David L Wirta, Sherif M El-Harazi, Michael E Tepedino, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 6, 2020
Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current TherapiesBridgitte Shen Lee, Alan G Kabat, Jason Bacharach, et al.
Ophthalmology|October 2, 2014
Double-masked, randomized, dose-response study of AR-13324 versus latanoprost in patients with elevated intraocular pressureJason Bacharach, Harvey B Dubiner, Brian Levy, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Cataract and Refractive Surgery|August 5, 2014
Efficacy of trabecular bypass stent through 2 years: data from the United States pivotal trialJason Bacharach
Clinical Ophthalmology (Auckland, N.Z.)|April 11, 2025
The Effect of Eyedrop Size on Pupillary Dilation Using the Nanodropper Bottle AdapterAudrey Chow, Jin Choi, Jason Bacharach
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 14, 2003
Comparison of the efficacy of the fixed-combination timolol/dorzolamide versus concomitant administration of timolol and dorzolamideJason Bacharach, Maria F Delgado, Andrew G Iwach
Therapeutic Advances in Ophthalmology|October 18, 2024
Early diagnostics and interventional glaucomaTiciana De Francesco, Jason Bacharach, Oluwatosin Smith, et al.
Journal of Cataract and Refractive Surgery|August 21, 2020
Impact of dexamethasone intraocular suspension 9% on intraocular pressure after routine cataract surgery: post hoc analysisCynthia Matossian, John Hovanesian, Jason Bacharach, et al.
Eye (London, England)|April 30, 2021
A review of acquired blepharoptosis: prevalence, diagnosis, and current treatment optionsJason Bacharach, Wendy W Lee, Andrew R Harrison, et al.
Clinical Ophthalmology (Auckland, N.Z.)|January 27, 2025
Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE StudyJason Bacharach, Ehsan Sadri, Gagan Sawhney, et al.
Ophthalmology. Glaucoma|March 5, 2025
Sepetaprost 0.002% Noninferiority vs. Timolol 0.5% in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: ANGEL-2David L Wirta, Sherif M El-Harazi, Michael E Tepedino, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 6, 2020
Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current TherapiesBridgitte Shen Lee, Alan G Kabat, Jason Bacharach, et al.
Ophthalmology|October 2, 2014
Double-masked, randomized, dose-response study of AR-13324 versus latanoprost in patients with elevated intraocular pressureJason Bacharach, Harvey B Dubiner, Brian Levy, et al.
Pageof 5